Wednesday, November 20, 2013

What is frovatriptan?



Frovatriptan is a triptan biologic developed by Vernalis for the analysis of cephalalgia headaches and for abbreviate appellation blockage of menstrual migraine. The artefact is accountant to Endo Pharmaceuticals in North America and Menarini in Europe.
Adverse effects:Serious but attenuate cardiac contest accept been appear in patients with accident factors predictive of CAD. These include: coronary avenue vasospasm, brief myocardial ischemia, myocardial infarction, ventricular tachycardia and ventricular fibrillation.


No comments:

Post a Comment